Danaher Corporation $DHR Shares Sold by SVB Wealth LLC

SVB Wealth LLC decreased its position in Danaher Corporation (NYSE:DHR) by 25.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,592 shares of the conglomerate’s stock after selling 5,624 shares during the quarter. SVB Wealth LLC’s holdings in Danaher were worth $3,798,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Sivia Capital Partners LLC lifted its stake in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares during the last quarter. First Trust Advisors LP boosted its holdings in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC grew its position in Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after buying an additional 886 shares during the last quarter. Ieq Capital LLC increased its holdings in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after buying an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC increased its holdings in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after buying an additional 325 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.1%

Shares of NYSE DHR opened at $170.98 on Monday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a one year low of $170.74 and a one year high of $242.80. The business has a 50-day moving average price of $191.25 and a two-hundred day moving average price of $212.54. The firm has a market capitalization of $121.01 billion, a PE ratio of 33.07, a PEG ratio of 2.29 and a beta of 0.81.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.88 EPS. As a group, analysts predict that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 10.80% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of several research reports. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 target price on Danaher in a report on Friday, April 17th. Barclays decreased their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Evercore boosted their price objective on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Finally, Guggenheim reduced their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $240.70.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.